CCR Special Seminar | Dr Ashwini Chand
Blockade of gp130-dependent cytokine signalling in cancer
Dr Ashwini Chand is a Head, Cancer Therapeutics Development Group, Olivia Newton-John Cancer Research Institute; Victorian Cancer Agency Fellow.
Webinar link (Password 107881)